相关实验视频
Updated: Jun 18, 2025

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.2K
在骨髓肉瘤中准WNT5B和WNT10B
Gustavo A Miranda-Carboni1,2, Susan A Krum2,3
1Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
Oncotarget
|August 5, 2024
概括
在WNT信号传输中.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- WNT信号传递在骨髓瘤扩散中起着作用,但其确切的功能 (支持或反对瘤起源) 是有争议的.
- 目前正在探索WNT通路调制剂作为骨髓瘤的潜在治疗方法.
- 特定的WNT配体,如WNT5B (β-catenin-independent) 和WNT10B (β-catenin-dependent),在骨髓瘤中表达.
研究的目的:
- 调查WNT信号在骨髓瘤中的双重作用.
- 为了比较针对WNT的治疗方法 (激活剂和抑制剂).
- 为了确定WNT连接物和通路的特异性是否影响治疗结果.
主要方法:
- 在骨髓瘤亚型中分析WNT5B和WNT10B的表达.
- 将WNT通路激活剂和抑制剂作为治疗策略的比较.
- 评估WNT连接体和通路激活对骨髓瘤进展的影响.
主要成果:
- WNT5B和WNT10B在不同的骨髓瘤瘤中表达.
- 这些配体调节骨髓瘤的不同组织学亚型.
- WNT调节器的有效性可能取决于特定的WNT连接体和激活途径.
结论:
- 在骨髓瘤中WNT信号传递的作用是复杂的,并且依赖于连接体.
- 针对WNT信号的治疗策略必须考虑涉及的特定WNT连接体和通路.
- 基于WNT通路激活的个性化治疗方法对于骨髓瘤治疗至关重要.
相关概念视频
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

